🌐 Other

Biology is becoming more engineerable through AI and biotech tooling, representing a Version One moment where the intersection of deep science and AI creates a significant investable opportunity.

Launching a special investment vehicle led by a former bio founder to back earliest-stage biotinkerers working through scientific and technical risk.

Ideal biotech founders are deeply technical but not traditionally trained in biology, bring outsider perspectives enabled by AI, collaborate with world-class scientists, and focus on commercializing existing research through creative regulatory paths.

Invested in four stealth-mode biotech companies spanning protein modeling, phage technology, AI cell design, and immune system mapping platforms.

AI and biotech tooling advances have compressed development cycles and enabled a new generation of technical founders to solve long-standing biology problems, making biotech investable at scale.

V1 is backing second-life EV battery storage solutions, with Moment Energy recognized as Global Cleantech 100 leader.

V1 is invested in composable DeFi infrastructure and stablecoins gaining scale, with MetaMask-Uniswap integration and Loon's CADC surpassing $300M volume.

V1 is focused on AI-native infrastructure and tools that integrate more context into AI-driven workflows for productivity gains.

Neo Financial raised nearly $70M in equity, moving toward a securitization model typical of major banks.

Shellworks raised $15M Series A to build compostable, biomass-based packaging solutions as plastic alternatives.